Cipla Medpro's Jerome Smith leaves CEO post

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad) from your shop to Alison Bryant (email | Twitter) and we will feature it here each Friday.

Cipla Medpro's Jerome Smith leaves CEO post

Cipla Medpro CEO Jerome Smith stepped down a few months after the company announced that he had been suspended because of "serious allegations" that it declined to specify at the time. Smith's resignation came just before a scheduled disciplinary hearing, at which he was set to face allegations that he gave himself bonuses and pay increases that weren't authorized by the board, and that he put 45 people on the payroll who weren't actually employees. More


Jerome Smith--Cipla Medpro
Smith resigned as CEO from Cipla Medpro.


Jane Wasman--Acorda Therapeutics
Wasman will serve as president, International.

Biotech

> Acorda Therapeutics ($ACOR) announced that Jane Wasman will serve as president, International. Release

> Aenova's Swiss Caps USA named Brad Carlson as vice president of marketing and sales. Release

> Aastrom Biosciences ($ASTM) announced that CEO Tim M. Mayleben plans to retire once the company has hired a successor. Release

> Cubist Pharmaceuticals ($CBST) announced that Tamara Joseph, senior vice president and general council, resigned. Release

> NeuroGeneration recruited Mohamedi Kagalwala as director of the new Division of Biotherapeutics and Drug Discovery. Release

> N30 Pharma names Sherif Gabriel as vice president of research. Release

> Vaxxas appointed David Hoey as CEO. Story

> NanoBio appointed David Peralta as CEO. Release

> Cerulean Pharma appointed Andres Tellez as senior manager of business development. Release

> Cytos Biotechnology appointed Christian Itin as CEO. Release

> MediStem appointed Alan Lewis as CEO. Release

> DCPrime appointed Marcel Zwaal as CEO and Anthony Hall as chief medical officer. Release

> Onconova Therapeutics appointed Thomas J. McKearn as president of research and development. Release

> Nabsys appointed Peter Lewis as CFO and Darren Lee as vice president of business development. Release

> Sequenom ($SQNM) announced the appointment of Bill Bowen as senior vice president and general counsel. Story

> Sirona Biochem named Neil Belenkie as CEO. Release

Medical Devices

> Becton, Dickinson ($BDX) announced that David V. Elkins, executive vice president and chief financial officer, will leave the company in November to pursue an entrepreneurial opportunity at Round Rock Research. Suketu Upadhyay, currently senior vice president and controller, will serve as interim CFO, effective Nov. 9. Release

> Sonoma Orthopedic Products appointed Rick Epstein as president and CEO, succeeding Glen Coleman. Release

> Accuray ($ARAY) CEO Euan Thompson stepped down after 10 years on the job. Former Mentor Corporation chief Josh Levine will replace him. Story

Biotech IT

> GNS Healthcare announced the expansion of its senior management team, adding Hans Winkler as chief scientific officer. Release

Suggested Articles

The FDA sent Eton's partner, Bausch Health, a complete response letter that raised “no concerns” about the clinical data in the drug’s application.

A new partnership will test drug cocktails containing Karyopharm's new product Xpovio in cell samples from glioblastoma patients.

Boehringer signed a deal to buy out a small immuno-oncology player this morning, and AbbVie’s been at it, too, inking a deal to snap up Mavupharma.